Advertisement

Topics

Latest "Convoy for a Cure" News Stories

03:20 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Convoy for a Cure" found in our extensive news archives from over 250 global news sources.

More Information about Convoy for a Cure on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Convoy for a Cure for you to read. Along with our medical data and news we also list Convoy for a Cure Clinical Trials, which are updated daily. BioPortfolio also has a large database of Convoy for a Cure Companies for you to search.

Showing "Convoy Cure" News Articles 1–25 of 1,100+

Friday 19th October 2018

Ascletis's Second HCV Treatment on Priority Review List in China

Ascletis Pharma of Hangzhou reported that its second hepatitis C treatment, ravidasvir, has been included in China's list of Proposed Priority Review drugs. Ascletis has submitted an NDA for ravidasvir, a China Category 1 candidate, as part of a two-drug combination treatment, along with already-approved Ganovo®. The combination, an all-oral interferon-free regimen, produced a 99% cure rate in...


DanaFarber Cancer Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryDanaFarber Cancer Institute Inc DanaFarber, formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prevention of cancer and related diseases. The institute has many ongoing clinical trials for cancer at DanaF...

The Low Down on Stem Cell Tourism for Neurological Diseases

Stem cell tourism is a global problem. The top three conditions marketed by such clinics are MS, PD, and stroke—often peddling false hope to patients who are vulnerable, desperately searching for a cure. 


Castle Creek Pharma Announces $71.8 Million in New Investment to Expand Research for Rare Dermatologic Conditions

Castle Creek Pharma secures new investment from Fidelity Management & Research Company and Valor Equity Partners towards the late stage development of Diacerein Ointment for the treatment of Epidermolysis Bullosa Simplex PARSIPPANY, N.J. (PRWEB) October 19, 2018 Castle Creek Pharma (Castle Creek), a US-based company which develops therapies for orphan dermatologic and other underserved condit...

Society for Immunotherapy of Cancer to Host 5-Day, Intensive Educational Program for Early Career Scientists and Clinicians

The Society for Immunotherapy of Cancer (SITC) has developed the first-of-its-kind five-day, in-depth cancer immunotherapy educational program in Mesa, Ariz. on Feb. 18-22, 2019. MILWAUKEE (PRWEB) October 19, 2018 The Society for Immunotherapy of Cancer (SITC) has developed the first-of-its-kind five-day, in-depth cancer immunotherapy educational program in Mesa, Ariz. on Feb. 18-22, 2019. The SI...

OncLive® Presents the Latest Science Summit™ on the Treatment of Ovarian Cancer and STS

Summit will feature distinguished professionals from the Stanford Cancer Center OncLive®, the leading digital provider of resources and information to oncology professionals, will host its latest State of the Science Summit™ on the treatment of ovarian cancer and soft tissue sarcoma. The event will take place on Thursday, Oct. 25 from 5 to 9 p.m. at...

Mohawk Industries Goes Pink for Breast Cancer at Corporate HQ in Georgia

SOURCE: Mohawk Industries DESCRIPTION:Employees at Mohawk Industries recently took part in their company-wide Pink Out to rally in support of Susan G. Komen. The annual event is part of the flooring manufacturer’s annual observance of Breast Cancer Awareness Month and took place at the corporate headquarters in Calhoun, Ga. Each year, employees come together to learn more about the company’s ...

Spanish Biotech Partners Gilead to Develop Functional HIV Cure

AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy.   The trial, which will run in Spain, is planned to start in early 2019 and ... The post Spanish Biotech Partners Gilead to Develop Functional HIV Cure appeared first on Labiotech.eu.

hVIVO builds on position of strength in challenge trials

Respiratory syncytial virus causes the common cold, for which there is no effective cure.

Thursday 18th October 2018

Scientists drew cartoons to help explain how cancer immunotherapy works. Those drawings were turned into a book called “A Cure Within.” Read the story here: https://buff.ly/2RWjO7N pic.twitter.com/IAfEvZd1tc

Scientists drew cartoons to help explain how cancer immunotherapy works. Those drawings were turned into a book called “A Cure Within.” Read the story here: https://buff.ly/2RWjO7N  pic.twitter.com/IAfEvZd1tc

Cystic Fibrosis Foundation Commits $100 Million to Infection Research

Funding will support improved detection, diagnosis, prevention, and treatment of infections related to CF The Cystic Fibrosis Foundation announced today that it will commit at least $100 million over the next five years as part of a sweeping effort to address the chronic and intractable infections that are a hallmark of cystic fibrosis (CF). The Infect...

Multiple Myeloma Experts, Patients, Advocates and Caregivers Team Up to Hike Mount Everest Base Camp

Sixteen hikers will take on this challenge to raise awareness and funds for multiple myeloma through the Multiple Myeloma Research Foundation To raise funds and awareness, a team of 18 individuals, including four patients, will take on an epic journey hiking Mount Everest base camp from Oct. 26 to Nov. 8. The trek is part of the Moving Mountains for ...

Ascletis' Ravidasvir NDA Proposed for Priority Review by the CFDA

HANGZHOU and SHAOXING, China, Oct. 18, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) announces today the New Drug Application (NDA) of Ravidasvir is on the List of Proposed Priority Review, according to the public notification by the China Food and Drug Administration (CFDA) on Oct 17th, 2018. Such Priority Review will accelerate Ravidasvir NDA approval process significantly. Ravid...

2014 Giants of Cancer Care® Inductee James P. Allison, Ph.D., Awarded the 2018 Nobel Prize in Physiology or Medicine

The Nobel Prize recognizes individuals whose discoveries benefit humankind. OncLive®, the leading digital provider of resources and information to oncology professionals, is pleased to announce that 2014 Giants of Cancer Care® inductee, James P. Allison, Ph.D., was recognized with the 2018 Nobel Prize in Physiology or Medicine for his research...

Let Your Kid Be a Hero, a Genetic Engineering Hero

Amino Labs announces the release of the world's first beginner's guide to genetic engineering for use at home, in the classroom, and in makerspaces LETHBRIDGE, Alberta (PRWEB) October 18, 2018 Learning hands-on genetic engineering skills just got a lot closer to home with the release of the world’s first beginner’s guide to genetic engineering. "Zero to Genetic Engineering Hero:...

AELIX and Gilead Collaborate to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

BARCELONA, Spain–(BUSINESS WIRE)–AELIX Therapeutics S.L. (“AELIX”), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for HIV infection, today announces that it has entered into a clinical research collaboration with Gilead Sciences, Inc. (“Gilead”), a research-based biopharmaceutical company that discovers, develops and comm...

The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend Their Collaboration to Investigate the Immuno-Competence of Urothelial Cancer Patients Receiving Immunotherapy

The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify biomarkers that predict therapeutic response and the incidence of immune-related adverse events (irAEs) in urothelial carcinoma patients treated with checkpoint inhibitors. In recent...

Gilead and Aelix join forces to pursue HIV ‘cure’

The HTI vaccine could replace antiretroviral therapy if it reaches market

Aflac Partners With the American Association for Cancer Research to Help Find a Cure for Breast Cancer

SOURCE: Aflac DESCRIPTION:According to the American Cancer Society, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States in 2018. You already know Aflac has supported childhood cancer research and treatment initiatives since 1995. But 

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

AELIX Therapeutics will investigate the safety, immunogenicity, and efficacy of AELIX Therapeutics’ HTI vaccine and Gilead´s Toll-Like Receptor 7 agonist vesatolimod (GS-9620) in HIV-infected individuals AELIX Therapeutics S.L. (“AELIX”), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for H...

Wednesday 17th October 2018

Global Urological Catheters Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Global Experts Reach Consensus on Thermalism Tourism in Chongqing

CHONGQING, China, Oct. 17, 2018 /PRNewswire/ -- West China's Chongqing, known as the Global Hot Spring Capital, has just witnessed a grand event for thermalism tourism. The First International Symposium on Hydrotherapy and Climatotherapy Tourism in China launched its opening ceremony on October 16 in Chongqing's northern Beibei District, and conferences and other activities were hel...

Mice study shows antibiotics are not always necessary to cure sepsis

Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice.

Charlotte Car Shows Hosting 1st Annual Car Show For A Cure

Come on out to 131-Main on Saturday, October 27th 2018 to celebrate the 1st Annual Car Show For A Cure! Enjoy lunch in the Blakeney Shopping Center and support a great cause. CHARLOTTE, N.C. (PRWEB) October 17, 2018 This event is in support of the ISF MIBG Ambassador program, and will be a gathering/car show to be enjoyed by both owners and the public. Visitors will have the opportunity to vote f...

Researchers Cure Drug-resistant Infections without Antibiotics

NewsBiochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks